Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: Concomitant reduction of serum tumour necrosis factor alpha and enhancement of anti-tumour activity

British Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 336-343

  Ching, L M ^a   Browne, W L ^a   Tchernegovski, R ^a   Gregory, T ^a   Baguley, B C ^a   Palmer, B D ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

5,6 Dimethylxanthenone 4 acetic acid; Anti tumour activity; Colon 38; Pentoxifylline; Phthalimide; Thalidomide; Tumour necrosis factor

Indexed keywords

5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; PENTOXIFYLLINE; PHTHALIMIDE; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD LEVEL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031846669     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.495     Document Type: Article

References (24)

1. Baguley BC, Calveley SB, Crowe KK, Fray LM, O'Rourke SA and Smith GP (1989) Comparisoin of the effects of flavone acetic acid, fostriecin, homoharringtonine and tumour necrosis factor alpha on Colon 38 tumors in mice. Eur J Cancer Clin Oncol 25: 263 269
2. Casini G and Ferappi M (1964) Preparation of one optical antipode of 2-phthalimidoglutarimide. Farmaco 19: 563-565
3. Ching L-M and Baguley BC (1987) Induction of natural killer cell activity by the antitumour compound flavone acetic acid (NSC 347512). Eur J Cancer Clin Oncol 23: 1047-1050
4. Ching L-M, Joseph WR, Zhuang L, Atwell GJ, Rewcastle GR, Denny WA and Baguley BC (1991) Induction of natural killer activity by xanthenone analogues of flavone acetic acid: relation with antitumour activity. Eur J Cancer 27: 79-83
5. Ching L-M, Xu Z-F, Gummer BH, Palmer BD, Joseph WR and Baguley BC (1995) Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid. Br J Cancer 72: 339-343
6. D'Amato RJ, Loughnan MS, Flynn E and Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082-4085
7. Fabro S, Smith RL and Williams RT (1967) Toxicity and teratogenicity of optical isomers of thlidomide. Nature 215: 296
8. Futami H, Eader LA, Back TT, Gruys E, Young HA, Wiltrout RH and Baguley BC (1992) Cytokine induction and therapeutic synergy with interleukin-2 against murine renal and colon cancers by xanthenone-4-acetic acid derivatives. J Immunother 12: 247-255
9. Han J, Thompson P and Beutler B (1990) Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 172: 391-394
10. Mace KF, Hornung RL, Wiltrout RH and Young HA (1990) Correlation between in vivo induction of cytokine gene expression by flavone acetic acid and strict dose dependency and therapeutic efficacy against murine renal cancer. Cancer Res 50: 1742-1747
11. Muhadevan V, Malik STA, Meager A, Fiers W, Lewis GP and Hart IR (1990) Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown. Cancer Res 50: 5537-5542
12. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA and Kaplan G (1993) Thalidomide exerts its inhibitory action on tumour necrosis factor alpha by enhancing mRNA degradation. J Exp Med 177: 1675-1680
13. Nishimura K, Hashimoto Y and Iwasaki S (1994) Enhancement of phorbol esterinduced production of tumor necrosis factor alpha by thalidomide. Biochem Biophys Res Commun 199: 455-460
14. Noel P, Nelson S, Bokulic R, Bagby G, Lippton H, Lipscomb G and Summer W (1990) Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci 47: 1023-1029
15. Philpott M, Baguley BC and Ching L-M (1995) Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid. Cancer Chemother Pharmacol 36: 143-148
16. Pratesi G, Rodolfo M, Rovetta G and Parmiani G (1990) Role of T cells and tumour necrosis factor in antitumour activity and toxicity of flavone acetic acid. Eur J Cancer 26: 1079-1083
17. Rewcastle GW, Atwell GJ, Baguley BC, Calveley SB and Denny WA (1989) Potential antitumor agents. 58. Synthesis and structure-activity relationships of substituted xanthenone-4-acetic acids active against the Colon 38 tumor in vivo. J Med Chem 32: 793-799
18. Rewcastle GW, Atwell GJ, Zhuang L, Baguley BC and Denny WA (1991) Potential antitumor agents. 61. Structure-activity relationships for in vivo colon-38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids. J Med Chem 34: 217-222
19. Sampaio EP, Sarno EN, Galilly R, Cohn ZA and Kaplan G (1991) Thalidomide selectively inhibits tumor necrosis factor-alpha production by stimulated human monocytes. J Exp Med 173: 699-703
20. Sasaki K, Shibata Y, Hashimoto Y and Iwasaki S (1995) Benzylphthalimides and phenethylphthalimides with thalidomide-like activity on the production of tumor necrosis factor alpha. Biol Pharmaceut Bull 18: 1228-1233
21. Shannon EJ and Sandoval F (1996) Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells. Immunopharmacol Immunotoxicol 18: 59-72
22. Teicher BA, Holden SA, Ara G and Northey D (1993) Response of the FSaII fibrosarcoma to antiangiogenic modulators plus cytotoxic agents. Anticancer Res 13: 2101-2106
23. Zwi LJ, Baguley BC, Gavin JB and Wilson WR (1989) Blood flow failure as a major determinant in the antitumor action of flavone acetic acid (NSC 347512). J Natl Cancer Inst 81: 1005-1013
24. Zwi LJ, Baguley BC, Gavin JB and Wilson WR (1994) Correlation between immune and vascular activities of xanthenone acetic acid antitumor agents. Oncol Res 6: 79-85